Reuters – Canada’s Goldcorp Inc agreed to buy gold miner Andean Resources Ltd for C$3.6 billion ($3.4 billion), trumping a competing offer from rival Eldorado Gold Corp .
Original post:
Corrected: Canada’s Goldcorp to buy Andean for $3.4 billion
(Reuters)
AP – Major banks are agreeing to give local governments and nonprofit groups the ability to buy foreclosed homes before they are sold to private investors.
View original here:
Banks to allow local groups to buy foreclosures
(AP)
AP – Taiwanese regulators on Tuesday rejected Primus Financial Holdings’ planned purchase of AIG’s Taiwan life insurance unit amid concerns that the Cayman Island-based firm may be backed by funds from rival China.
Read the original here:
Taiwan rejects Primus purchase of AIG unit
(AP)
AP – Taiwanese regulators on Tuesday rejected Primus Financial Holdings’ planned purchase of AIG’s Taiwan life insurance unit amid concerns that the Cayman Island-based firm may be backed by funds from rival China.
See the original post:
Taiwan rejects Primus purchase of AIG unit
(AP)
Reuters – No client is too small for Goldman Sachs Group Inc these days, even a company with no revenue that’s owned by a hedge fund specializing in penny stocks.
Read the original here:
Goldman swims downstream for PetroAlgae IPO
(Reuters)
Britain’s economy is still struggling to pull out of the doldrums. There’s on-going concern about inflation, and the new government is set to embark on the biggest round of spending cuts in a generation. But one area of the economy that remains resilient — and has throughout the recession — is Scotch whisky.
Britain’s economy is still struggling to pull out of the doldrums. There’s on-going concern about inflation, and the new government is set to embark on the biggest round of spending cuts in a generation. But one area of the economy that remains resilient — and has throughout the recession — is Scotch whisky.
Reuters – Pressure mounted on Genzyme as its shares rose 6 percent in Europe a day after French drugmaker Sanofi-Aventis made public its month-old proposal to buy the U.S. biotech for $18.5 billion.
Read the rest here:
Sanofi proposal heaps pressure on Genzyme
(Reuters)
Reuters – France’s Sanofi-Aventis on Sunday publicly disclosed its $18.5 billion, $69-per-share cash offer for Genzyme Corp in a bid to rouse shareholders after failing to engage the U.S. biotechnology company in merger talks.
Read the original post:
Sanofi makes $18.5 billion Genzyme offer public
(Reuters)
Recent Comments